Search by Drug Name or NDC

    NDC 12496-0003-02 OPVEE 2.7 mg/100uL Details

    OPVEE 2.7 mg/100uL

    OPVEE is a NASAL SPRAY in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Indivior Inc.. The primary component is NALMEFENE HYDROCHLORIDE.

    Product Information

    NDC 12496-0003
    Product ID 12496-0003_74d3ee90-30a9-4586-be30-e8093621593e
    Associated GPIs
    GCN Sequence Number 084821
    GCN Sequence Number Description nalmefene HCl SPRAY 2.7 MG NASAL
    HIC3 H3T
    HIC3 Description OPIOID ANTAGONISTS
    GCN 54207
    HICL Sequence Number 010052
    HICL Sequence Number Description NALMEFENE HCL
    Brand/Generic Brand
    Proprietary Name OPVEE
    Proprietary Name Suffix n/a
    Non-Proprietary Name nalmefene hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SPRAY
    Route NASAL
    Active Ingredient Strength 2.7
    Active Ingredient Units mg/100uL
    Substance Name NALMEFENE HYDROCHLORIDE
    Labeler Name Indivior Inc.
    Pharmaceutical Class Opioid Antagonist [EPC], Opioid Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA217470
    Listing Certified Through 2024-12-31

    Package

    NDC 12496-0003-02 (12496000302)

    NDC Package Code 12496-0003-2
    Billing NDC 12496000302
    Package 2 BLISTER PACK in 1 CARTON (12496-0003-2) / 1 VIAL, SINGLE-DOSE in 1 BLISTER PACK (12496-0003-1) / 100 uL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2023-10-02
    NDC Exclude Flag N
    Pricing Information N/A